journal article·2026-06Open access

Laparoscopic Delivery of a MnO 2 ‐P‐ICG Patch for Photodynamic Therapy and NK Cell‐Driven Immunotherapy in Hepatocellular Carcinoma

Jie Lin, Haoqi Pan, Ke Wu, Junjie Nan, Jinyao Dai, Yushun Chang, Hao Shen, Qingxuan Ye, Haowen Lu, Yuxuan Shen, Boqiang Liu, Ming Wu, Jicheng Yu, Xiujun Cai, Dong Cen

Advanced Science· Volume 13· Issue 32

Abstract

ABSTRACT Recurrence and metastasis are the primary causes of mortality in hepatocellular carcinoma (HCC), primarily driven by an immunosuppressive tumor microenvironment. This study developed a multifunctional flexible patch (MnO 2 ‐P‐ICG NFs) based on electrospun SiO 2 gel fibers whose surface is modified with a layer of “nest‐like” MnO 2 . The patch enables the co‐delivery of indocyanine green (ICG) and pachymaran directly to the tumor site via a laparoscopic system. Under near‐infrared light irradiation, ICG serves as a photosensitizer for photodynamic therapy (PDT), effectively ablating tumors and inducing immunogenic cell death (ICD), thereby activating antitumor immunity. Meanwhile, pachymaran, with its immunomodulatory effects, preferential activates natural killer (NK) cells to exert antitumor effects. Additionally, PDT further enhances this immune response by activating the cGAS‐STING pathway. In mouse models, implantation of the patch significantly inhibited primary liver tumor progression and ascites formation. In a malignant liver tumor model, MnO 2 ‐P‐ICG NFs prevented local recurrence in 80% of treated mice. Notably, both the depletion of NK cells and the blockade of the cGAS‐STING pathway compromised the therapeutic efficacy of MnO 2 ‐P‐ICG NFs. Clinically, tumors with higher NK cell infiltration were associated with improved patient outcomes. In conclusion, this versatile patch provides a promising therapeutic strategy for patients with advanced HCC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · interferon and immune responses · Cancer Research and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of General Surgery Sir Run‐Run Shaw Hospital Zhejiang University Hangzhou China

National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments Sir Run‐Run Shaw Hospital Zhejiang University Hangzhou China

Department of Pancreatic Surgery Fudan University Shanghai Cancer Center Shanghai China

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious Diseases The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

Hepatobiliary Technology Key Laboratory of Fujian Province Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou China

State Key Laboratory of Advanced Drug Delivery and Release Systems Zhejiang Key Laboratory of New Drug Intelligent Innovation For Metabolic Diseases School of Pharmacy Zhejiang University Hangzhou China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (47)

Show source-provided references
1. 10.1056/NEJMra171326310.1056/NEJMra1713263 ↗
2. 10.1038/s41572‐020‐00240‐310.1038/s41572‐020‐00240‐3 ↗
3. 10.1038/s41568‐021‐00383‐910.1038/s41568‐021‐00383‐9 ↗
4. 10.1038/nri316910.1038/nri3169 ↗
5. 10.1002/hep.3274010.1002/hep.32740 ↗
6. 10.1172/JCI6638110.1172/JCI66381 ↗
7. 10.4049/jimmunol.090136210.4049/jimmunol.0901362 ↗
8. 10.1016/j.clim.2008.08.01210.1016/j.clim.2008.08.012 ↗
9. 10.1016/j.jhep.2009.07.01310.1016/j.jhep.2009.07.013 ↗
10. 10.1002/hep.2305410.1002/hep.23054 ↗
11. Combination of NK‐Based Immunotherapy and Sorafenib Against Hepatocellular Carcinoma
12. 10.1111/jcmm.1356410.1111/jcmm.13564 ↗
13. 10.1016/j.ijbiomac.2014.04.01010.1016/j.ijbiomac.2014.04.010 ↗
14. 10.1038/s41565‐018‐0319‐410.1038/s41565‐018‐0319‐4 ↗
15. 10.1016/j.biomaterials.2020.11982710.1016/j.biomaterials.2020.119827 ↗
16. 10.1016/j.jconrel.2016.05.06210.1016/j.jconrel.2016.05.062 ↗
17. 10.1038/nrc107110.1038/nrc1071 ↗
18. 10.1021/cr900236h10.1021/cr900236h ↗
19. 10.1136/jitc-2020-00192610.1136/jitc-2020-001926 ↗
20. 10.1021/nn405773r10.1021/nn405773r ↗
21. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
22. Hydrodynamics of Soft Active Matter
23. 10.1038/nri392110.1038/nri3921 ↗
24. 10.1038/ncb358610.1038/ncb3586 ↗
25. 10.1016/j.immuni.2014.10.01710.1016/j.immuni.2014.10.017 ↗
26. 10.1016/j.immuni.2018.03.01710.1016/j.immuni.2018.03.017 ↗
27. 10.3390/nu1521452710.3390/nu15214527 ↗
28. 10.1038/srep4050810.1038/srep40508 ↗
29. 10.1021/acsami.4c0707210.1021/acsami.4c07072 ↗
30. 10.1021/acsnano.4c0548310.1021/acsnano.4c05483 ↗
31. 10.1021/acsnano.4c0861310.1021/acsnano.4c08613 ↗
32. 10.1158/0008‐5472.CAN‐24‐162410.1158/0008‐5472.CAN‐24‐1624 ↗
33. 10.1038/s41575‐022‐00704‐910.1038/s41575‐022‐00704‐9 ↗
34. 10.1038/s41392‐023‐01332‐810.1038/s41392‐023‐01332‐8 ↗
35. 10.1038/s41467‐020‐18425‐510.1038/s41467‐020‐18425‐5 ↗
36. 10.1016/j.sbi.2019.08.00310.1016/j.sbi.2019.08.003 ↗
37. 10.1126/science.aaz889910.1126/science.aaz8899 ↗
38. 10.1016/j.biomaterials.2019.01.01510.1016/j.biomaterials.2019.01.015 ↗
39. 10.1038/s41422‐020‐00395‐410.1038/s41422‐020‐00395‐4 ↗
40. 10.1038/s41565‐021‐00962‐910.1038/s41565‐021‐00962‐9 ↗
41. 10.1002/anie.20201495910.1002/anie.202014959 ↗
42. 10.1002/1878‐0261.1285110.1002/1878‐0261.12851 ↗
43. 10.1021/acs.chemrev.8b0039610.1021/acs.chemrev.8b00396 ↗
44. 10.1158/1078‐0432.CCR‐13‐314110.1158/1078‐0432.CCR‐13‐3141 ↗
45. 10.1053/j.gastro.2013.03.05210.1053/j.gastro.2013.03.052 ↗
46. 10.1158/2159‐8290.CD‐20‐162810.1158/2159‐8290.CD‐20‐1628 ↗
47. 10.1016/j.neo.2014.07.00910.1016/j.neo.2014.07.009 ↗